{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T22:06:50Z","timestamp":1787954810073,"version":"build-2784847793"},"reference-count":46,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2018,12,1]],"date-time":"2018-12-01T00:00:00Z","timestamp":1543622400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Surgical Oncology"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1016\/j.suronc.2018.09.004","type":"journal-article","created":{"date-parts":[[2018,9,18]],"date-time":"2018-09-18T13:41:03Z","timestamp":1537278063000},"page":"688-694","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":37,"title":["The role of hepatectomy for synchronous liver metastases from pancreatic adenocarcinoma"],"prefix":"10.1016","volume":"27","author":[{"given":"Andreas","family":"Andreou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sebastian","family":"Knitter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fritz","family":"Klein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Malinka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Moritz","family":"Schmelzle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benjamin","family":"Struecker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosa B.","family":"Schmuck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alina Roxana","family":"Noltsch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniela","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Uwe","family":"Pelzer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Timm","family":"Denecke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johann","family":"Pratschke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcus","family":"Bahra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"19","key":"10.1016\/j.suronc.2018.09.004_bib1","doi-asserted-by":"crossref","first-page":"1817","DOI":"10.1056\/NEJMoa1011923","article-title":"FOLFIRINOX versus gemcitabine for metastatic pancreatic cancer","volume":"364","author":"Conroy","year":"2011","journal-title":"N. Engl. J. Med."},{"issue":"18","key":"10.1016\/j.suronc.2018.09.004_bib2","doi-asserted-by":"crossref","first-page":"1691","DOI":"10.1056\/NEJMoa1304369","article-title":"Increased survival in pancreatic cancer with nab-paclitaxel plus gemcitabine","volume":"369","author":"Von Hoff","year":"2013","journal-title":"N. Engl. J. Med."},{"issue":"14","key":"10.1016\/j.suronc.2018.09.004_bib3","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.1001\/jama.2013.279201","article-title":"Adjuvant chemotherapy with gemcitabine and long-term outcomes among patients with resected pancreatic cancer: the CONKO-001 randomized trial","volume":"310","author":"Oettle","year":"2013","journal-title":"J. Am. Med. Assoc."},{"issue":"1","key":"10.1016\/j.suronc.2018.09.004_bib4","doi-asserted-by":"crossref","first-page":"7","DOI":"10.3322\/caac.21387","article-title":"Cancer statistics","volume":"67","author":"Siegel","year":"2017","journal-title":"CA Cancer J Clin"},{"issue":"1","key":"10.1016\/j.suronc.2018.09.004_bib5","first-page":"23","article-title":"Radiologic resectability assessment in pancreatic cancer","volume":"186","author":"Denecke","year":"2014","journal-title":"R\u00f6fo"},{"issue":"6","key":"10.1016\/j.suronc.2018.09.004_bib6","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1097\/MPA.0000000000000365","article-title":"Cytoreductive surgery for pancreatic cancer improves overall outcome of gemcitabine-based chemotherapy","volume":"44","author":"Bahra","year":"2015","journal-title":"Pancreas"},{"issue":"22","key":"10.1016\/j.suronc.2018.09.004_bib7","first-page":"2140","article-title":"Pancreatic adenocarcinoma","volume":"371","author":"Ryan","year":"2014","journal-title":"N. Engl. J. Med."},{"issue":"5","key":"10.1016\/j.suronc.2018.09.004_bib8","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1097\/00000658-199305010-00002","article-title":"One hundred and forty-five consecutive pancreaticoduodenectomies without mortality","volume":"217","author":"Cameron","year":"1993","journal-title":"Ann. Surg."},{"issue":"3 Suppl","key":"10.1016\/j.suronc.2018.09.004_bib9","first-page":"S37","article-title":"Accomplishments in 2007 in the treatment of metastatic pancreatic cancer","volume":"2","author":"Louvet","year":"2008","journal-title":"Gastrointest Cancer Res"},{"issue":"4","key":"10.1016\/j.suronc.2018.09.004_bib10","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1097\/SLA.0b013e318263da2f","article-title":"Pancreatic ductal adenocarcinoma: is there a survival difference for R1 resections versus locally advanced unresectable tumors? What is a \"true\" R0 resection?","volume":"257","author":"Konstantinidis","year":"2013","journal-title":"Ann. Surg."},{"issue":"12","key":"10.1016\/j.suronc.2018.09.004_bib11","first-page":"1395","article-title":"S3-guideline exocrine pancreatic cancer","volume":"51","author":"Seufferlein","year":"2013","journal-title":"Z. Gastroenterol."},{"issue":"8","key":"10.1016\/j.suronc.2018.09.004_bib12","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.6004\/jnccn.2017.0131","article-title":"Pancreatic adenocarcinoma, version 2.2017, NCCN clinical practice guidelines in oncology","volume":"15","author":"Tempero","year":"2017","journal-title":"J. Natl. Compr. Canc. Netw."},{"issue":"4","key":"10.1016\/j.suronc.2018.09.004_bib13","first-page":"366","article-title":"Is liver resection in metastases of exocrine pancreatic carcinoma justified?","volume":"67","author":"Klempnauer","year":"1996","journal-title":"Chirurg"},{"issue":"4","key":"10.1016\/j.suronc.2018.09.004_bib14","first-page":"524","article-title":"Hepatic resection for noncolorectal nonendocrine liver metastases: analysis of 1,452 patients and development of a prognostic model","volume":"244","author":"Adam","year":"2006","journal-title":"Ann. Surg."},{"issue":"1","key":"10.1016\/j.suronc.2018.09.004_bib15","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.surg.2016.02.019","article-title":"Synchronous resections of hepatic oligometastatic pancreatic cancer: disputing a principle in a time of safe pancreatic operations in a retrospective multicenter analysis","volume":"160","author":"Tachezy","year":"2016","journal-title":"Surgery"},{"key":"10.1016\/j.suronc.2018.09.004_bib16","first-page":"939350","article-title":"The impact of simultaneous liver resection for occult liver metastases of pancreatic adenocarcinoma","author":"Klein","year":"2012","journal-title":"Gastroenterol Res Pract"},{"issue":"3","key":"10.1016\/j.suronc.2018.09.004_bib17","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1097\/SLA.0000000000001240","article-title":"Pancreatogastrostomy versus pancreatojejunostomy for RECOnstruction after PANCreatoduodenectomy (RECOPANC, DRKS 00000767): perioperative and long-term results of a multicenter randomized controlled trial","volume":"263","author":"Keck","year":"2016","journal-title":"Ann. Surg."},{"issue":"5","key":"10.1016\/j.suronc.2018.09.004_bib18","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1007\/s00534-005-0999-7","article-title":"Nomenclature of hepatic anatomy and resections: a review of the Brisbane 2000 system","volume":"12","author":"Strasberg","year":"2005","journal-title":"J Hepatobiliary Pancreat Surg"},{"issue":"1","key":"10.1016\/j.suronc.2018.09.004_bib19","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.surg.2005.05.001","article-title":"Postoperative pancreatic fistula: an international study group (ISGPF) definition","volume":"138","author":"Bassi","year":"2005","journal-title":"Surgery"},{"issue":"6","key":"10.1016\/j.suronc.2018.09.004_bib20","doi-asserted-by":"crossref","first-page":"1651","DOI":"10.1245\/s10434-008-9839-8","article-title":"Most pancreatic cancer resections are R1 resections","volume":"15","author":"Esposito","year":"2008","journal-title":"Ann. Surg Oncol."},{"issue":"11","key":"10.1016\/j.suronc.2018.09.004_bib21","doi-asserted-by":"crossref","first-page":"2484","DOI":"10.1002\/cncr.23074","article-title":"Is resection of periampullary or pancreatic adenocarcinoma with synchronous hepatic metastasis justified?","volume":"110","author":"Gleisner","year":"2007","journal-title":"Cancer"},{"key":"10.1016\/j.suronc.2018.09.004_bib22","first-page":"579672","article-title":"Pancreatic resections for advanced M1-pancreatic carcinoma: the value of synchronous metastasectomy","author":"Seelig","year":"2010","journal-title":"HPB Surg"},{"issue":"3\u20134","key":"10.1016\/j.suronc.2018.09.004_bib23","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1159\/000313532","article-title":"Treatment of metachronous and simultaneous liver metastases of pancreatic cancer","volume":"44","author":"Dunschede","year":"2010","journal-title":"Eur. Surg. Res."},{"issue":"91\u201392","key":"10.1016\/j.suronc.2018.09.004_bib24","first-page":"881","article-title":"Pancreatic cancer with distant metastases: a contraindication for radical surgery?","volume":"56","author":"Yamada","year":"2009","journal-title":"Hepato-Gastroenterology"},{"issue":"1","key":"10.1016\/j.suronc.2018.09.004_bib25","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1245\/s10434-006-9131-8","article-title":"Pancreatic resection for M1 pancreatic ductal adenocarcinoma","volume":"14","author":"Shrikhande","year":"2007","journal-title":"Ann. Surg Oncol."},{"issue":"2","key":"10.1016\/j.suronc.2018.09.004_bib26","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1016\/j.ejso.2016.10.023","article-title":"Radical surgery of oligometastatic pancreatic cancer","volume":"43","author":"Hackert","year":"2017","journal-title":"Eur. J. Surg. Oncol."},{"issue":"1","key":"10.1016\/j.suronc.2018.09.004_bib27","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.surg.2014.02.009","article-title":"Extended pancreatectomy in pancreatic ductal adenocarcinoma: definition and consensus of the International Study Group for Pancreatic Surgery (ISGPS)","volume":"156","author":"Hartwig","year":"2014","journal-title":"Surgery"},{"issue":"6","key":"10.1016\/j.suronc.2018.09.004_bib28","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1097\/01.sla.0000145965.86383.89","article-title":"A two-stage hepatectomy procedure combined with portal vein embolization to achieve curative resection for initially unresectable multiple and bilobar colorectal liver metastases","volume":"240","author":"Jaeck","year":"2004","journal-title":"Ann. Surg."},{"issue":"8","key":"10.1016\/j.suronc.2018.09.004_bib29","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1200\/JCO.2010.32.6132","article-title":"High survival rate after two-stage resection of advanced colorectal liver metastases: response-based selection and complete resection define outcome","volume":"29","author":"Brouquet","year":"2011","journal-title":"J. Clin. Oncol."},{"issue":"1","key":"10.1016\/j.suronc.2018.09.004_bib30","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1097\/00000658-200201000-00011","article-title":"Hepatic resection for metastatic tumors from gastric cancer","volume":"235","author":"Okano","year":"2002","journal-title":"Ann. Surg."},{"issue":"5","key":"10.1016\/j.suronc.2018.09.004_bib31","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1067\/msy.2003.147","article-title":"Surgical resection of liver metastases of gastric cancer: an analysis of a 17-year experience with 22 patients","volume":"133","author":"Sakamoto","year":"2003","journal-title":"Surgery"},{"issue":"11","key":"10.1016\/j.suronc.2018.09.004_bib32","doi-asserted-by":"crossref","first-page":"1974","DOI":"10.1007\/s11605-014-2623-0","article-title":"Response to preoperative chemotherapy predicts survival in patients undergoing hepatectomy for liver metastases from gastric and esophageal cancer","volume":"18","author":"Andreou","year":"2014","journal-title":"J. Gastrointest. Surg."},{"issue":"6","key":"10.1016\/j.suronc.2018.09.004_bib33","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1097\/01.sla.0000128305.90650.71","article-title":"Recurrence and outcomes following hepatic resection, radiofrequency ablation, and combined resection\/ablation for colorectal liver metastases","volume":"239","author":"Abdalla","year":"2004","journal-title":"Ann. Surg."},{"issue":"12","key":"10.1016\/j.suronc.2018.09.004_bib34","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1016\/S1470-2045(13)70447-9","article-title":"Perioperative FOLFOX4 chemotherapy and surgery versus surgery alone for resectable liver metastases from colorectal cancer (EORTC 40983): long-term results of a randomised, controlled, phase 3 trial","volume":"14","author":"Nordlinger","year":"2013","journal-title":"Lancet Oncol."},{"issue":"22","key":"10.1016\/j.suronc.2018.09.004_bib35","doi-asserted-by":"crossref","first-page":"3677","DOI":"10.1200\/JCO.2008.20.5278","article-title":"Improved survival in metastatic colorectal cancer is associated with adoption of hepatic resection and improved chemotherapy","volume":"27","author":"Kopetz","year":"2009","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.suronc.2018.09.004_bib36","doi-asserted-by":"crossref","DOI":"10.1200\/JCO.2018.36.18_suppl.LBA4001","article-title":"ASCO Annual Meeting: unicancer GI Prodige 24\/CCTG PA.6 trial: a multicenter international randomized phase III trial of adjuvant mFOLFIRINOX versus gemcitabine (gem) in patients with resected pancreatic ductal adenocarcinomas","volume":"36","author":"Conroy","year":"2018","journal-title":"J. Clin. Oncol."},{"issue":"3","key":"10.1016\/j.suronc.2018.09.004_bib37","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1097\/SLA.0000000000001850","article-title":"Locally advanced pancreatic cancer: neoadjuvant therapy with folfirinox results in resectability in 60% of the patients","volume":"264","author":"Hackert","year":"2016","journal-title":"Ann. Surg."},{"issue":"9617","key":"10.1016\/j.suronc.2018.09.004_bib38","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1016\/S0140-6736(08)60455-9","article-title":"Perioperative chemotherapy with FOLFOX4 and surgery versus surgery alone for resectable liver metastases from colorectal cancer (EORTC Intergroup trial 40983): a randomised controlled trial","volume":"371","author":"Nordlinger","year":"2008","journal-title":"Lancet"},{"issue":"33","key":"10.1016\/j.suronc.2018.09.004_bib39","doi-asserted-by":"crossref","first-page":"5344","DOI":"10.1200\/JCO.2008.17.5299","article-title":"Pathologic response to preoperative chemotherapy: a new outcome end point after resection of hepatic colorectal metastases","volume":"26","author":"Blazer","year":"2008","journal-title":"J. Clin. Oncol."},{"issue":"21","key":"10.1016\/j.suronc.2018.09.004_bib40","doi-asserted-by":"crossref","first-page":"2338","DOI":"10.1001\/jama.2009.1755","article-title":"Association of computed tomography morphologic criteria with pathologic response and survival in patients treated with bevacizumab for colorectal liver metastases","volume":"302","author":"Chun","year":"2009","journal-title":"Jama"},{"issue":"36","key":"10.1016\/j.suronc.2018.09.004_bib41","doi-asserted-by":"crossref","first-page":"4566","DOI":"10.1200\/JCO.2012.45.2854","article-title":"Optimal morphologic response to preoperative chemotherapy: an alternate outcome end point before resection of hepatic colorectal metastases","volume":"30","author":"Shindoh","year":"2012","journal-title":"J. Clin. Oncol."},{"issue":"15","key":"10.1016\/j.suronc.2018.09.004_bib42","doi-asserted-by":"crossref","first-page":"2778","DOI":"10.1002\/cncr.28097","article-title":"Multicenter validation study of pathologic response and tumor thickness at the tumor-normal liver interface as independent predictors of disease-free survival after preoperative chemotherapy and surgery for colorectal liver metastases","volume":"119","author":"Brouquet","year":"2013","journal-title":"Cancer"},{"issue":"1","key":"10.1016\/j.suronc.2018.09.004_bib43","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.hpb.2015.07.009","article-title":"Total pancreatectomy for pancreatic ductal adenocarcinoma: review of the National Cancer Data Base","volume":"18","author":"Johnston","year":"2016","journal-title":"HPB"},{"issue":"6","key":"10.1016\/j.suronc.2018.09.004_bib44","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1097\/SLA.0b013e318283a4d1","article-title":"Margin status remains an important determinant of survival after surgical resection of colorectal liver metastases in the era of modern chemotherapy","volume":"257","author":"Andreou","year":"2013","journal-title":"Ann. Surg."},{"issue":"3","key":"10.1016\/j.suronc.2018.09.004_bib45","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1097\/SLA.0000000000001731","article-title":"Pancreatic cancer surgery: the new R-status counts","volume":"265","author":"Strobel","year":"2017","journal-title":"Ann. Surg."},{"key":"10.1016\/j.suronc.2018.09.004_bib46","doi-asserted-by":"crossref","DOI":"10.1016\/j.clnu.2018.01.002","article-title":"Effect of an enhanced recovery after surgery protocol in patients undergoing pancreaticoduodenectomy: a randomized controlled trial","author":"Takagi","year":"2018","journal-title":"Clin. Nutr."}],"container-title":["Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960740418302792?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960740418302792?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,1,9]],"date-time":"2019-01-09T18:10:16Z","timestamp":1547057416000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0960740418302792"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,12]]},"references-count":46,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["S0960740418302792"],"URL":"https:\/\/doi.org\/10.1016\/j.suronc.2018.09.004","relation":{},"ISSN":["0960-7404"],"issn-type":[{"value":"0960-7404","type":"print"}],"subject":[],"published":{"date-parts":[[2018,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The role of hepatectomy for synchronous liver metastases from pancreatic adenocarcinoma","name":"articletitle","label":"Article Title"},{"value":"Surgical Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.suronc.2018.09.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}